In mCRPC patients with BRCA1/2 or ATM alterations, first-line treatment with abiraterone plus prednisone and olaparib improves OS.

Hope is on the horizon for patients with aggressive, inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with ...

Dana Soday marked two years of cancer treatment Wednesday with her final infusion at the Ochsner Cancer Center — and a declaration that she is cancer-free.

SAN ANTONIO -- Bilateral mastectomy as initial treatment for women with breast cancer and a pathogenic BRCA1 variant was not linked to better survival, according to an international analysis. Compared ...

Germline BRCA mutations have an adverse impact on both progression-free and overall survival in patients with hormone receptor-positive/HER2-negative metastatic ...

Credit: Getty Images. The cumulative incidence of pregnancy at 10 years was 22%. The median time from breast cancer diagnosis to conception was 3.5 years. Patients who have been treated for ...

BEERSE, Belgium, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has ...